Antepartum corticosteroids: Disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (4) , 1148-1153
- https://doi.org/10.1016/0002-9378(94)90054-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Corticosteroids for Enhanced Fetal Lung Maturation in Patients with HELLP Syndrome: Impact on NeonatesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1993
- Corticosteroids for the Enhancement of Fetal Lung Maturity: Impact on the Gravida with Preeclampsia and the HELLP SyndromeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1993
- Care of the Pregnancy Complicated by HELLP SyndromeObstetrics and Gynecology Clinics of North America, 1991
- Pregnancy Complicated by Preeclampsia-Eclampsia With the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet CountObstetrics & Gynecology, 1990
- The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing?American Journal of Obstetrics and Gynecology, 1990
- Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsiaAmerican Journal of Obstetrics and Gynecology, 1986
- Thrombocytopenia in preeclampsia: Associated abnormalities and management principlesAmerican Journal of Obstetrics and Gynecology, 1984
- A CONTROLLED TRIAL OF ANTEPARTUM GLUCOCORTICOID TREATMENT FOR PREVENTION OF THE RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTSPediatrics, 1972